Navigation Links
Terascala Closes Additional Funding Based on Strong OEM Sales and Release of ISB
Date:11/5/2013

Boston, MA (PRWEB) November 05, 2013

Terascala, the fast data company, today announced the closing of additional funding from existing venture capitalists and several new investors. Ascent Venture Partners, Harborlight Capital Partners, and Thomas Weisel Partners co-led the equity investment. In addition, the company also signed a significant financing package with Bridge Bank, N.A. of San Jose, Calif. Under the terms of the financing package, Terascala secured two lines of working capital as well as an additional asset based lending facility. Details of the funding were not made public.

Over the last few months, Terascala has transitioned the company to a pure original equipment manufacturer (OEM) sales model and as a result, has been able to reorganize the company in such a manner to better support the needs of their primary OEM partners. OEM sales, primarily thru Dell and NetApp grew by over 100 percent in 2012 and are expected to finish 2013 with annual growth exceeding 75 percent. The business has grown significantly in the higher education, energy, and genomics markets, where the company’s partners have strong solutions and a significant presence.

The funding round will enable additional investments in Terascala’s latest product, the Intelligent Storage Bridge (ISB). Released in Q3, the ISB has already resulted in several orders and provides Terascala’s OEMs the potential to market integrated high-performance computing (HPC) and network-attached storage (NAS) solutions, an industry first. The ISB is a high-performance workflow manager designed to transfer large data sets quickly and automatically between fast scratch storage and enterprise storage.

Terascala’s products can be seen in the Dell booth #1301 and NetApp booth #601 at SC13 on November 17-22, 2013 at the Colorado Convention Center, Denver, Colorado.

“I am excited to announce the additional funding and the continued support of our investor syndicate. They are seeing the OEM sales growth and also hearing from enterprise customers that TeraOS-powered storage platforms in combination with ISB help establish the most efficient HPC infrastructure. Users are empowered with an easy to use, highly scalable, and highly reliable file system, rich analytics to optimize performance, and a high performance workflow with direct access to their project data at any point in the workflow," said Steve Butler, CEO for Terascala.

“Terascala is making great strides in its OEM business model, and we are excited about the company’s future. We were particularly pleased to see the growth and initial sales of the ISB with Dell, NetApp and other channel partners; we believe that the company will continue to grow at a rapid rate and are pleased to be an investor in the company,” added Walter Dick, Managing Partner, Ascent Venture Partners.

About Terascala

Terascala is the fast data company. Terascala storage appliances dramatically accelerate the time to insight for organizations that rely on simulation, analysis, and modeling tools to bring new products and innovation to market. Exclusively available through strategic partners Dell and NetApp, Terascala storage appliances provide on-demand throughput at multiple gigabytes per second while leveraging industry-leading storage platforms for long-term data protection. Learn more at http://www.terascala.com/.

Connect with Terascala
Read our blog: http://www.terascala.com/blog
Follow us on Twitter: http://www.twitter.com/terascala_inc
Watch a video: http://www.terascala.com/about-terascala-video/

Terascala and the Terascala logo are trademarks of Terascala, Inc. All other brands, products, or service names may be trademarks or property of their respective holders.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11208478.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Terascala Special Report Features Gartner Research to Help R&D and IT Users Accelerate Performance with HPC Storage Appliances
2. The University of North Texas Installs Terascala in Its New High-Performance Computing Cluster
3. Terascala Advances Its Vision of Optimizing High-Performance Computing Workflows for Faster Time to Results
4. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
5. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
6. OncoSec Closes $7.75 Million Public Offering
7. AyoxxA Biosystems Closes Series A Financing Round
8. Enviva Closes on $120 Million Senior Secured Credit Facility
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
11. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):